Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Akush Ginekol (Sofiia) ; 43(4): 32-5, 2004.
Artigo em Búlgaro | MEDLINE | ID: mdl-15318541

RESUMO

The aim of this study is to establish the possibilities for effective influence upon the postoperative nausea and vomiting and to summarize the existing literature data. The observation is carried out upon 361 patients with performed hysterectomy, who were hospitalised at the Department of Obstetrics and Gynecology of the University Hospital "Saint George" Plovdiv for the period January-December 2003 year. We performed randomized study about the effect of the application of dexamethasone used in the introduction of anaesthesia and its effect upon the postoperative nausea and vomiting. Our observation confirms the literature data about the safe and effective application of dexamethasone as a method of choice for minimizing the frequency of the postoperative nausea and vomiting


Assuntos
Antieméticos/uso terapêutico , Dexametasona/uso terapêutico , Histerectomia , Náusea e Vômito Pós-Operatórios/prevenção & controle , Medicação Pré-Anestésica/métodos , Adulto , Idoso , Antieméticos/administração & dosagem , Dexametasona/administração & dosagem , Feminino , Humanos , Pessoa de Meia-Idade , Náusea e Vômito Pós-Operatórios/etiologia , Fatores de Risco , Estatísticas não Paramétricas , Resultado do Tratamento
3.
Ann Fr Anesth Reanim ; 31(10): 783-7, 2012 10.
Artigo em Francês | MEDLINE | ID: mdl-22784474

RESUMO

OBJECTIVE: Storage of cisatracurium at room temperature seems to have no effect on its degradation in vitro contrary to the recommendations of storage at +4°C. The purpose of this study was to evaluate the influence of cisatracurium' s storage temperature on its onset time. STUDY DESIGN: Prospective, randomized, double-blind trial study. PATIENTS AND METHODS: Thirty patients were enrolled. The control group consisted of 15 patients receiving cisatracurium (0.15mg/kg) stored at room temperature and the intervention consisted of 15 patients receiving cisatracurium (0.15mg/kg) stored at +4°C. The primary endpoint was to compare cisatracurium onset time depending on the storage temperature. RESULTS: Cisatracurium onset time was 235 (180-292) seconds in the "room temperature" group vs. 240 (210-292) seconds in the "refrigerated" group. There was no difference between the onset of cisatracurium depending on the temperature of storage (p=0.51). Subgroups analysis in the "room temperature" group did not show any difference in cisatracurium onset depending on whether it was stored at room temperature for one, two or three weeks. Excellent intubation score was obtained for 100% of the patients. CONCLUSION: This study demonstrated that cisatracurium's storage at room temperature had no influence on its onset time. It provides an argument for the preservation of cisatracurium at room temperature for a period not exceeding 21 days. Monitoring the onset of curarization may increase the quality score of intubation.


Assuntos
Anestesia , Atracúrio/análogos & derivados , Armazenamento de Medicamentos , Fármacos Neuromusculares não Despolarizantes/química , Adulto , Idoso , Atracúrio/química , Método Duplo-Cego , Estabilidade de Medicamentos , Determinação de Ponto Final , Feminino , Humanos , Intubação Intratraqueal , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Refrigeração , Temperatura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA